Fontan术后先天性心脏病患者肝脏结节的多模态筛查:超声、ARFI弹性成像、CT与MRI的作用
本研究为横断面研究,前瞻性纳入49例Fontan术后患者,行临床评估、ARFI弹性成像、超声、CT和MRI检查。超声检出3/49(6.1%)肝脏结节,CT检出14/44(31.8%),MRI检出19/48(39.6%)。有结节者ARFI肝硬度显著高于无结节者(2.64±0.81 m/s vs 1.94±0.49 m/s,p=0.002),AUC为0.767(p=0.002)。
要点
- Fontan术后患者肝脏结节CT检出率31.8%、MRI检出率39.6%,均明显高于超声的6.1%。
- 有肝结节者ARFI肝硬度2.64±0.81 m/s,显著高于无结节者的1.94±0.49 m/s(p=0.002)。
- ARFI弹性成像预测肝结节的AUC为0.767(p=0.002),可能有助于指导进一步行CT或MRI检查。
核心结论
- 超过三分之一的Fontan术后患者在CT或MRI上发现肝脏结节,而超声未检出多数结节;有结节者ARFI肝硬度显著更高,弹性成像可能有助于指导进一步CT或MRI检查。
研究设计与样本
- 横断面研究,2014年8月至2016年6月前瞻性招募49例Fontan术后患者,行临床评估、ARFI弹性成像、超声、CT和MRI检查。
关键影像表现/征象
- 超声检出肝脏结节3/49例(6.1%),CT检出14/44例(31.8%),MRI检出19/48例(39.6%)。
诊断标准与关键数值
- ARFI弹性成像肝硬度预测肝结节的AUC为0.767(p=0.002)。
- 有肝结节者ARFI肝硬度为2.64±0.81 m/s,无结节者为1.94±0.49 m/s,组间差异p=0.002。
临床应用与阅片要点
- 超声对Fontan术后患者肝脏结节的检出率低(6.1%),CT和MRI检出率更高(31.8%和39.6%)。
- ARFI弹性成像肝硬度显著升高者可能更需进一步行CT或MRI检查(原文结论为may help guiding which patient should be further imaged with CT or MRI)。
- 临床及实验室资料(包括Fontan术后时间)与肝结节存在无显著相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Currently, there is no consensus in the literature regarding the screening of hepatic nodules in patients who have undergone the Fontan procedure. The objectives of this study are to evaluate in this population the frequency of hepatic nodules at ultrasound (US), CT, and MRI; to measure liver stiffness using acoustic radiation force impulse (ARFI) elastography; and to investigate predictive factors for hepatic nodules.
SUBJECTS AND METHODS: In this cross-sectional study, 49 patients who underwent the Fontan procedure were prospectively recruited from August 2014 through June 2016. These patients underwent clinical evaluation for hepatic disorders, ARFI elastography, US, CT, and MRI.
RESULTS: Most of the patients had no symptoms, and hepatic nodules were detected in three of 49 (6.1%) patients at US, 14 of 44 (31.8%) patients at CT, and 19 of 48 (39.6%) patients at MRI. Liver stiffness at ARFI elastography was significantly higher in patients with hepatic nodules than in patients without such nodules (2.64 ± 0.81 m/s vs 1.94 ± 0.49 m/s; p = 0.002) and was a significant predictor of hepatic nodule (AUC, 0.767; p = 0.002). No clinical or laboratory data had any significant correlation with the existence of hepatic nodules, including time since Fontan procedure.
CONCLUSION: In our study, more than one-third of patients had hepatic nodules at CT or MRI, but US did not detect most hepatic nodules. Liver stiffness at ARFI elastography was significantly higher in patients with hepatic nodules, and it may help guiding which patient should be further imaged with CT or MRI.
引用
- Horvat N, Rocha MS, Chagas AL, et al. Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI. AJR Am J Roentgenol. 2018. PMID: 30247977. doi:10.2214/AJR.18.19762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。